HillSignal

TICKER INTELLIGENCE

Amgen Inc. ($AMGN)

$385.16 2.4% (7d)

NYSE/NASDAQ: AMGN

Washington Intelligence

5

Active Bills

0

Gov't Contracts

50

Congressional Trades

Amgen is a publicly traded company in the Technology sector. This company operates across Technology and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 5 active Congressional signals mentioning Amgen, including 5 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.

Congressional Trades in $AMGN

50 filings
Alan Armstrong
SELL $15,001 - $50,000 — Amgen Inc. - Common Stock

⚠️ PRESIDENTIAL ACTION: Presidential Memorandum signed 7/30/2026: "Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended". This DPA action will boost investment and production in domestic critical mineral recycling and processing, likely increasing stock valuations for pure-play recovery companies and defense contractors reliant on secure rare-earth magnet supplies, while potentially raising costs for import-dependent manufacturers.

2026-07-21
1 flag
David J. Taylor
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]

Rep. Taylor bought $1K-$15K in AEP on June 5, 2026 — 5 days before the Wildfire Prevention Act (S.140) cleared committee, which could affect power infrastructure for forest areas.

2026-06-12
5 flags
Maria Elvira Salazar
SELL $15,001 - $50,000 — Amgen Inc

Rep. Salazar bought $3K-$45K in UNH on April 22, 2026 — just 6 days after HR8324 (Great American Healthcare Plan) was introduced, a bill that expands HSA provisions and could benefit health insurers like UnitedHealth Group.

2026-05-11
1 flag
Maria Elvira Salazar
SELL $15,001 - $50,000 — Amgen Inc. - Common Stock (AMGN)

System: No valid trades to analyze

2026-05-08
1 flag
Mark Warner
SELL $1,001 - $15,000 — Amgen Inc
SELL $1,001 - $15,000 — Amgen Inc

Rep. Warner bought $1K-$15K in WFC on April 13, 2026 — 15 days before S.4419 was introduced, a bill that would reduce compliance costs for U.S. banks like Wells Fargo by exempting them from beneficial ownership reporting.

2026-05-01
2 flags
Maria Elvira Salazar
BUY $15,001 - $50,000 — Amgen Inc

System: No overlapping signals found

2026-04-22
1 flag
Maria Elvira Salazar
BUY $15,001 - $50,000 — Amgen Inc. - Common Stock (AMGN) [ST]

System: No valid trades to analyze

2026-04-21
1 flag
Rohit KhannaD-CA
BUY $1,001 - $15,000 — AMGEN INC CMN

System: No valid trades to analyze

2026-04-07
1 flag
David Taylor
SELL $1,001 - $15,000 — Amgen Inc

System: No overlapping signals found

2026-03-09
1 flag
David J. TaylorR-OH
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]

Rep. David J. Taylor sold $1,001 - $15,000 in AAPL on 2026-02-26 — 4 days before S3956, the "Make Billionaires Pay Their Fair Share Act," was introduced, which could lead to capital reallocation.

2026-03-06
5 flags
David Taylor
SELL $1,001 - $15,000 — Amgen Inc
BUY $1,001 - $15,000 — Amgen Inc

System: No overlapping signals found

2026-02-03
1 flag
David J. TaylorR-OH
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]

David J. Taylor bought $1,001 - $15,000 in AAPL on 2026-01-16, 6 days before HR7085, which repeals conflict mineral disclosure requirements, was placed on the Union Calendar.

2026-02-02
5 flags
Julia LetlowR-LA
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock

System: No suspicious timing patterns detected

2026-01-13
1 flag
David Taylor
SELL $1,001 - $15,000 — Amgen Inc (1)

System: No suspicious timing patterns detected

2025-12-08
1 flag
David J. TaylorR-OH
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock

Rep. Taylor bought $1,001 - $15,000 in V (Visa Inc.) on 2025-12-03, 1 day before the HUSTLE Act (S3378) was introduced, which proposes tax-exempt NIL investment accounts that could expand the market for financial services.

2025-12-05
5 flags
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-10-29
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock

Marjorie Taylor Greene bought $1,001 - $15,000 in HD (Home Depot, Inc.) on 2025-10-24, 27 days before the introduction of HR6217 ("Revitalize Our Neighborhoods Act of 2025"), a bill that could increase demand for construction and renovation services.

2025-10-28
5 flags
Lisa McClainR-MI
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock

System: No suspicious timing patterns detected

2025-10-22
1 flag
Sheldon Whitehouse
SELL $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-10-03
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-09-29
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock

Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in CRWD on 2025-09-11, 40 days before the Foreign Robocall Elimination Act (S2666) was enacted, a bill that could increase demand for advanced analytics and fraud detection.

2025-09-27
5 flags
Daniel Meuser
SELL $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-08-21
1 flag
Daniel MeuserR-PA
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock

Daniel Meuser sold $50K-$100K in GOOGL on 2025-02-11, 135 days before the STOP CSAM Act of 2025 (S1829) advanced to the Senate Legislative Calendar, a bill that directly increases liability for online platforms.

2025-08-20
5 flags
Lisa McClain
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-08-14
1 flag
Lisa McClainR-MI
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock

System: No suspicious timing patterns detected

2025-08-13
1 flag
Cliff Bentz
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-07-10
1 flag
Cliff BentzR-OR
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock

Rep. Bentz bought $1,001-$15,000 in AMGN on June 6, 2025 — 1 day after the "Treat and Reduce Obesity Act of 2025" (S1973) was introduced, a bill aiming to expand Medicare coverage for obesity treatments.

2025-07-09
1 flag
Scott Mr Franklin
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-07-04
1 flag
Scott Scott FranklinR-FL
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]

Representative Franklin bought $1,001 - $15,000 in AMGN on 2024-08-07, 245 days before the BRAIN Act (HR2767) was introduced, a bill aiming to increase research for brain tumor treatment.

2025-07-03
5 flags
Jefferson Shreve
SELL $15,001 - $50,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-06-23
1 flag
Jefferson ShreveR-IN
SELL $15,001 - $50,000 — Amgen Inc. - Common Stock (AMGN) [ST]

System: No suspicious timing patterns detected

2025-06-22
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-05-20
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN)

Marjorie Taylor Greene bought $1,001 - $15,000 in LLY on 2025-05-14, 5 days before the DeOndra Dixon INCLUDE Project Act of 2025 (HR3491) was introduced and referred to the Committee on Energy and Commerce.

2025-05-19
5 flags
Tommy Tuberville
SELL $15,001 - $50,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-05-15
1 flag
Rohit KhannaD-CA
BUY $1,001 - $15,000 — AMGEN INC. CMN

System: No suspicious timing patterns detected

2025-05-12
1 flag
Jared Moskowitz
BUY $1,001 - $15,000 — Amgen Inc (2)

System: No suspicious timing patterns detected

2025-05-12
1 flag
Jefferson Shreve
BUY $15,001 - $50,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-05-09
1 flag
Jared MoskowitzD-FL
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN)
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN)

System: No suspicious timing patterns detected

2025-05-09
1 flag
Rob BresnahanR-PA
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock

System: No suspicious timing patterns detected

2025-05-08
1 flag
Jefferson ShreveR-IN
BUY $15,001 - $50,000 — Amgen Inc. - Common Stock (AMGN) [ST]

System: No suspicious timing patterns detected

2025-05-08
1 flag
Marjorie Taylor Greene
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2025-05-07
1 flag
Marjorie Taylor GreeneR-GA
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN)

System: No suspicious timing patterns detected

2025-05-06
1 flag
Jefferson ShreveR-IN
BUY $15,001 - $50,000 — Amgen Inc. - Common Stock

Representative Shreve bought $15,001 - $50,000 in AMGN on February 24, 2025 — 8 days before the EPIC Act of 2025 (S832) was introduced, which proposes to extend market exclusivity for small-molecule drugs.

2025-03-09
5 flags
Emily RandallD-WA
SELL $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN) [ST]

Rep. Randall sold $1K-$15K in AMGN (Amgen) on Jan 6, 2025 — 3 days before the Skinny Labels, Big Savings Act (S43) was introduced, a bill that creates a safe harbor for generic drug manufacturers and is bearish for branded drug makers.

2025-02-11
3 flags
Rohit KhannaD-CA
BUY $1,000,001 - $5,000,000 — AMGEN INC. CMN

System: No suspicious timing patterns detected

2025-01-08
1 flag
Virginia FoxxR-NC
BUY $1,001 - $15,000 — Amgen Inc. - Common Stock (AMGN)

Rep. Foxx bought $1K-$15K in JNJ on Dec 6, 2024 — 62 days before HR1062 (Growing and Preserving Innovation in America Act of 2025) was introduced, a bill that would permanently lock in higher tax deductions for US multinationals, directly benefiting Johnson & Johnson's foreign IP income.

2025-01-06
2 flags
Rohit KhannaD-CA
BUY $1,001 - $15,000 — AMGEN INC. CMN

System: No suspicious timing patterns detected

2024-12-05
1 flag
Ro Khanna
BUY $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2024-11-11
1 flag
Rohit KhannaD-CA
BUY $1,001 - $15,000 — AMGEN INC. CMN

System: No suspicious timing patterns detected

2024-11-08
1 flag
Sheldon Whitehouse
SELL $1,001 - $15,000 — Amgen Inc

System: No suspicious timing patterns detected

2024-10-10
1 flag

Congressional Legislation Affecting Amgen Inc. ($AMGN)

HR6624 forces a structural onshoring of U.S. synthetic biology IP and manufacturing away from PRC entities. Domestic pure-plays Ginkgo Bioworks ($DNA) and Twist Bioscience ($TWST) are direct beneficiaries, while large biopharma Amgen ($AMGN) and Regeneron ($REGN) face near-term capex pressure but reduced long-term IP risk. The bill advanced out of committee with bipartisan support and has an identical Senate companion bill, increasing passage probability.

Near-term capex pressure from building or contracting domestic manufacturing capacity; long-term reduction in IP theft risk and supply chain security

HR6624

The Protecting Americans from Unsafe Drugs Act of 2026 (HR7980) would expand FDA mandatory recall authority from controlled substances to all drugs, increasing structural operational risk and compliance costs for major pharmaceutical manufacturers. The bill is at an early legislative stage with a single Democratic sponsor, giving it low near-term passage probability. Market data shows the sector is already under pressure in April 2026 with JNJ, PFE, MRK, and AZN all down significantly over 30 days, but this bill is not yet being priced in as a material risk.

Manufacturers face increased compliance costs for recall infrastructure and higher potential liability from mandatory recalls.

HR7980

HR8032 (FAIC Act) is an early-stage bill requiring separate Medicare Part B payment for qualifying cancer drugs, eliminating a hospital incentive to avoid expensive branded oncology therapies. The bill protects $50B+ in oncology drug revenue for major pharma companies but faces a long legislative path through two committees. Current stock prices for affected tickers are near the bottom of their 52-week ranges, suggesting market pessimism is already priced in, creating asymmetric upside if the bill advances.

Hospitals must receive separate, pass-through payment at ASP for qualifying cancer drugs, removing the financial disincentive against administering high-cost branded oncology therapies that would otherwise be absorbed into bundled payments.

HR8032

The ABC Safe Drug Act (S. 1407) is in early legislative stages, having been referred to the Senate Finance Committee. It phases in restrictions on federal health programs purchasing drugs with Chinese active ingredients by 2030 and provides temporary tax incentives for domestic pharmaceutical manufacturing. Major pharma stocks ($PFE, $MRK, $JNJ, $LLY, $AMGN) show mixed but broadly negative 7-day changes, reflecting sector headwinds rather than this nascent bill. No market-moving impact is imminent.

Amgen faces procurement compliance costs but can claim 100% bonus depreciation on domestic manufacturing investments.

S1407

HR6485 (Skinny Labels, Big Savings Act) creates a statutory safe harbor protecting generic and biosimilar manufacturers from patent infringement liability when marketing drugs for non-patented indications, directly reversing the GlaxoSmithKline v. Teva precedent. Generic makers TEVA and VTRS are structural winners, with reduced litigation risk supporting their generic launch strategies. Brand-name manufacturers AMGN, PFE, JNJ, and MRK face accelerated competitive erosion on their top-selling drugs. The bill is early-stage (referred to House Judiciary), but companion Senate bill S43 signals bipartisan interest.

Accelerated market entry of generic and biosimilar competitors for branded drugs' non-patented indications, eroding sales volume and pricing power on those uses. Brand manufacturers lose the ability to use method-of-use patents indirectly to block skinny label competition.

HR6485

Understanding These Signals

Get Full Access to Amgen Inc. ($AMGN) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →